Neuro-Hitech is a biopharmaceutical company that focuses on developing drugs for the treatment of neurodegenerative diseases. Its product, Huperzine A, is clinically tested for safety in the treatment of Alzheimer's disease. The company s programs include disease-modifying compounds for AD that block aggregation of B-amyloid and tau-proteins. Neuro-Hitech s partners with the National Institutes of Health and the Georgetown University Medical Center. The company works under a cooperative research and development agreement with the Walter Reed Army Institute to study the potential for using Huperzine A for a range of applications that include a nerve gas antidote. It serves the biotechnology industry.
Neuro-Hitech is a holding company with assets currently in the Oil and Gas sector and in the pharmaceutical sector.
The company is focusing on expanding its presence as a junior oil and gas production and exploration company focusing on growth in Texas and primarily the Ft. Worth Basin. http://www.otcmarkets.com/stock/NHPI/profile